JP2017506622A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017506622A5 JP2017506622A5 JP2016549241A JP2016549241A JP2017506622A5 JP 2017506622 A5 JP2017506622 A5 JP 2017506622A5 JP 2016549241 A JP2016549241 A JP 2016549241A JP 2016549241 A JP2016549241 A JP 2016549241A JP 2017506622 A5 JP2017506622 A5 JP 2017506622A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- formula
- protein
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(CC*(CCC*1CCOCC1)C(OC1=C(Cc2ccc[o]2)*C2=C(Cc3ccccc3)*C(c3ccccc3)=C*12)=O)C(c(cc1)ccc1OC)=O Chemical compound C*(CC*(CCC*1CCOCC1)C(OC1=C(Cc2ccc[o]2)*C2=C(Cc3ccccc3)*C(c3ccccc3)=C*12)=O)C(c(cc1)ccc1OC)=O 0.000 description 5
- BUFSEVFXVCFYKY-UHFFFAOYSA-N O=C(C(Cc1ccc[o]1)=N1)N2C1=C(Cc1ccccc1)NC(c1ccccc1)=C2 Chemical compound O=C(C(Cc1ccc[o]1)=N1)N2C1=C(Cc1ccccc1)NC(c1ccccc1)=C2 BUFSEVFXVCFYKY-UHFFFAOYSA-N 0.000 description 2
- MWOYPGFRXPPBOX-UHFFFAOYSA-N O=C(C(Cc1ccccc1)=N1)N2C1=C(Cc1ccccc1)NC(c1ccccc1)=C2 Chemical compound O=C(C(Cc1ccccc1)=N1)N2C1=C(Cc1ccccc1)NC(c1ccccc1)=C2 MWOYPGFRXPPBOX-UHFFFAOYSA-N 0.000 description 2
- LNGUITKMTOZNAL-UHFFFAOYSA-N Oc(cc1)ccc1C1=CN(C(C(Cc2ccc[o]2)=N2)=O)C2=C(Cc2ccccc2)N1 Chemical compound Oc(cc1)ccc1C1=CN(C(C(Cc2ccc[o]2)=N2)=O)C2=C(Cc2ccccc2)N1 LNGUITKMTOZNAL-UHFFFAOYSA-N 0.000 description 2
- KAEGGIFPLJZUOZ-UHFFFAOYSA-N Oc(cc1)ccc1C1=CN(C(C(Cc2ccccc2)=N2)=O)C2=C(Cc2ccccc2)N1 Chemical compound Oc(cc1)ccc1C1=CN(C(C(Cc2ccccc2)=N2)=O)C2=C(Cc2ccccc2)N1 KAEGGIFPLJZUOZ-UHFFFAOYSA-N 0.000 description 2
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oc1ccc(CC2=NC3=C(Cc4ccccc4)NC(c(cc4)ccc4O)=CN3C2=O)cc1 Chemical compound Oc1ccc(CC2=NC3=C(Cc4ccccc4)NC(c(cc4)ccc4O)=CN3C2=O)cc1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 description 2
- LABFYLKLEVXOBL-UHFFFAOYSA-N CC(NC(CC[O]=O)C(NC(CC(O)=O)C(N(C)CCCN(CCCN1CCOCC1)C(Oc1c(Cc2ccc[o]2)nc2[n]1cc(-c1ccccc1)nc2Cc1ccccc1)=O)=O)=O)=O Chemical compound CC(NC(CC[O]=O)C(NC(CC(O)=O)C(N(C)CCCN(CCCN1CCOCC1)C(Oc1c(Cc2ccc[o]2)nc2[n]1cc(-c1ccccc1)nc2Cc1ccccc1)=O)=O)=O)=O LABFYLKLEVXOBL-UHFFFAOYSA-N 0.000 description 1
- NMILGIZTAZXMTM-UHFFFAOYSA-N CCCN1CCOCC1 Chemical compound CCCN1CCOCC1 NMILGIZTAZXMTM-UHFFFAOYSA-N 0.000 description 1
- QEUJTSCVVGEZCB-UHFFFAOYSA-N CN(CCCN(CCCN1CCOCC1)C(Oc1c(Cc2ccc[o]2)nc2[n]1cc(-c1ccccc1)nc2Cc1ccccc1)=O)C1(COCC(O)=O)OC1 Chemical compound CN(CCCN(CCCN1CCOCC1)C(Oc1c(Cc2ccc[o]2)nc2[n]1cc(-c1ccccc1)nc2Cc1ccccc1)=O)C1(COCC(O)=O)OC1 QEUJTSCVVGEZCB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461933210P | 2014-01-29 | 2014-01-29 | |
| US61/933,210 | 2014-01-29 | ||
| PCT/US2015/013504 WO2015116806A1 (en) | 2014-01-29 | 2015-01-29 | Pro-substrates for live cell applications |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017506622A JP2017506622A (ja) | 2017-03-09 |
| JP2017506622A5 true JP2017506622A5 (enExample) | 2018-03-08 |
| JP6588917B2 JP6588917B2 (ja) | 2019-10-09 |
Family
ID=52462487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549241A Active JP6588917B2 (ja) | 2014-01-29 | 2015-01-29 | 生細胞への適用のためのプロ基質 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9927430B2 (enExample) |
| EP (1) | EP3099691B1 (enExample) |
| JP (1) | JP6588917B2 (enExample) |
| WO (1) | WO2015116806A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9927430B2 (en) | 2014-01-29 | 2018-03-27 | Promega Corporation | Pro-substrates for live cell applications |
| WO2015116867A1 (en) | 2014-01-29 | 2015-08-06 | Promega Corporation | Quinone-masked probes as labeling reagents for cell uptake measurements |
| US10513694B2 (en) | 2015-06-25 | 2019-12-24 | Promega Corporation | Thienopyrrole compounds and uses thereof |
| JP7092677B2 (ja) | 2016-02-15 | 2022-06-28 | プロメガ コーポレイション | セレンテラジン類似体 |
| JP6978492B2 (ja) * | 2016-09-09 | 2021-12-08 | プロメガ コーポレイションPromega Corporation | 二重保護されたプロセレンテラジン基質 |
| JP7139330B2 (ja) | 2016-12-01 | 2022-09-20 | プロメガ コーポレイション | 細胞不透過性セレンテラジンアナログ |
| WO2018125992A1 (en) | 2016-12-28 | 2018-07-05 | Promega Corporation | Functionalized nanoluc inhibitors |
| EP3395803A1 (en) * | 2017-04-28 | 2018-10-31 | Institut Pasteur | Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins |
| JP7419260B2 (ja) | 2018-05-01 | 2024-01-22 | プロメガ コーポレイション | ＮａｎｏＬｕｃ自殺基質としてのセレンテラジン化合物 |
| WO2019232384A1 (en) | 2018-06-01 | 2019-12-05 | Promega Corporation | Inhibitors of oplophorus luciferase-derived bioluminescent complexes |
| BR112021006298A2 (pt) | 2018-10-03 | 2021-07-06 | Promega Corp | composições e métodos para estabilizar coelenterazina e análogos e derivados da mesma |
| JP7599074B2 (ja) | 2019-04-16 | 2024-12-13 | マックス－プランク－ゲゼルシャフト ツール フェルデルンク デル ヴィッセンシャフテン エー．ファウ． | 円順列変異ハロアルカントランスフェラーゼ融合分子 |
| EP3816180A1 (en) | 2019-10-31 | 2021-05-05 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Circularly permutated haloalkane transferase fusion molecules |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3477549D1 (en) | 1983-08-17 | 1989-05-11 | Allied Signal Inc | Gas generator and method of generating gas |
| US5683888A (en) | 1989-07-22 | 1997-11-04 | University Of Wales College Of Medicine | Modified bioluminescent proteins and their use |
| ES2301160T3 (es) | 1994-01-03 | 2008-06-16 | Promega Corporation | Luciferasas mutantes. |
| US6387675B1 (en) | 1994-01-03 | 2002-05-14 | Promega Corporation | Mutant luciferases |
| GB9501170D0 (en) | 1994-03-23 | 1995-03-08 | Secr Defence | Luciferases |
| JP3648763B2 (ja) | 1994-08-23 | 2005-05-18 | 日本油脂株式会社 | ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法 |
| GB9417593D0 (en) | 1994-09-01 | 1994-10-19 | Secr Defence | Luciferase labelling method |
| US5670356A (en) | 1994-12-12 | 1997-09-23 | Promega Corporation | Modified luciferase |
| AU707243B2 (en) | 1995-01-20 | 1999-07-08 | Promega Corporation | Mutant luciferases |
| JPH08294397A (ja) | 1995-04-27 | 1996-11-12 | Nippon Oil & Fats Co Ltd | 免疫学的活性物質の測定方法 |
| US5998204A (en) | 1997-03-14 | 1999-12-07 | The Regents Of The University Of California | Fluorescent protein sensors for detection of analytes |
| GB9707486D0 (en) | 1997-04-11 | 1997-05-28 | Secr Defence | Enzyme assays |
| US6429286B1 (en) | 1997-04-16 | 2002-08-06 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Immunoregulatory molecules for costimulatory signal transduction |
| US6602677B1 (en) | 1997-09-19 | 2003-08-05 | Promega Corporation | Thermostable luciferases and methods of production |
| WO1999014336A2 (en) | 1997-09-19 | 1999-03-25 | Promega Corporation | Thermostable luciferases and methods of production |
| GB9823468D0 (en) | 1998-10-28 | 1998-12-23 | Secr Defence | Novel enzyme |
| ATE374820T1 (de) | 1999-10-26 | 2007-10-15 | Secr Defence | Mutantenluciferase |
| GB9925161D0 (en) | 1999-10-26 | 1999-12-22 | Secr Defence | Novel enzyme |
| DE60142761D1 (de) | 2000-04-26 | 2010-09-23 | Chisso Corp | Oplophorus Luciferase |
| US7118878B1 (en) | 2000-06-09 | 2006-10-10 | Promega Corporation | Method for increasing luminescence assay sensitivity |
| US7879540B1 (en) | 2000-08-24 | 2011-02-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
| WO2002022854A2 (en) | 2000-09-13 | 2002-03-21 | Merck Patent Gmbh | Method for the detection and measurement of biomass |
| US7268229B2 (en) | 2001-11-02 | 2007-09-11 | Promega Corporation | Compounds to co-localize luminophores with luminescent proteins |
| CA2474695A1 (en) | 2002-02-01 | 2003-08-14 | Promega Corporation | Bioluminescent protease assay |
| AU2003267245C1 (en) | 2002-09-20 | 2008-05-29 | Promega Corporation | Luminescence-based methods and probes for measuring cytochrome P450 activity |
| EP1413584B1 (en) | 2002-10-21 | 2005-03-02 | AXXAM S.r.l. | Photoprotein with improved bioluminescence |
| AU2003300008B2 (en) | 2002-12-23 | 2007-04-05 | Promega Corporation | Improved luciferase-based assays |
| DE10303265A1 (de) | 2003-01-28 | 2004-07-29 | Roche Diagnostics Gmbh | Fluorimetrische Bestimmung von Analyten durch ein intramolekulares Quencher-Fluorophor-Konjugat |
| US7429472B2 (en) | 2003-01-31 | 2008-09-30 | Promega Corporation | Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule |
| EP1594962B1 (en) | 2003-01-31 | 2014-08-27 | Promega Corporation | Covalent tethering of functional groups to proteins |
| AU2004210982B2 (en) | 2003-02-12 | 2008-12-18 | Promega Corporation | Methods and kits for dual enzymatic assays whereby light is quenched from luminescent reactions |
| US20040178545A1 (en) | 2003-03-14 | 2004-09-16 | Cates Larry E. | System for optically analyzing a molten metal bath |
| US7922891B2 (en) | 2003-05-23 | 2011-04-12 | Arizona Board Of Regents | Methods for detection and quantification of analytes |
| WO2005038029A2 (en) | 2003-10-10 | 2005-04-28 | Promega Corporation | Luciferase biosensor |
| ATE443070T1 (de) | 2004-01-08 | 2009-10-15 | Univ Zuerich | Metallkomplexe mit vitamin b12 als ligand |
| US7416854B2 (en) | 2004-01-22 | 2008-08-26 | Promega Corporation | Luminogenic and nonluminogenic multiplex assay |
| US7553632B2 (en) | 2004-01-22 | 2009-06-30 | Promega Corporation | Luminogenic and nonluminogenic multiplex assay |
| EP2395358B1 (en) | 2004-07-30 | 2017-03-29 | Promega Corporation | Covalent tethering of functional groups to proteins |
| US7425436B2 (en) | 2004-07-30 | 2008-09-16 | Promega Corporation | Covalent tethering of functional groups to proteins and substrates therefor |
| US20070087400A1 (en) | 2004-07-30 | 2007-04-19 | Aldis Darzins | Covalent tethering of functional groups to proteins and substrates therefor |
| US7728118B2 (en) | 2004-09-17 | 2010-06-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
| EP2272973B1 (en) | 2005-05-31 | 2015-05-27 | Promega Corporation | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| EP1935986B1 (en) | 2005-05-31 | 2014-04-16 | Promega Corporation | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| KR20080039431A (ko) | 2005-08-17 | 2008-05-07 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 생물학적으로 활성인 혈청 파라옥소나제의 수준을 구하기위한 방법 및 조성물 |
| EP2004813B1 (en) | 2006-04-03 | 2015-06-03 | Promega Corporation | Permuted and nonpermuted luciferase biosensors binding cyclic nucleotides |
| CA2667697A1 (en) | 2006-10-30 | 2008-05-08 | Promega Corporation | Mutant hydrolase proteins with enhanced kinetics and functional expression |
| WO2008086035A2 (en) | 2007-01-10 | 2008-07-17 | Promega Corporation | Split mutant hydrolase fusion reporter and uses thereof |
| US20080248511A1 (en) | 2007-03-26 | 2008-10-09 | Promega Corporation | Methods to quench light from optical reactions |
| WO2009061413A2 (en) | 2007-11-05 | 2009-05-14 | Promega Corporation | Hybrid fusion reporter and uses thereof |
| EP2281046B1 (en) | 2008-05-19 | 2012-01-25 | Promega Corporation | LUCIFERASE BIOSENSORS FOR cAMP |
| JP5753083B2 (ja) | 2008-07-22 | 2015-07-22 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | Ａｄｐ検出に基づく発光ホスホトランスフェラーゼまたはａｔｐヒドロラーゼのアッセイ法 |
| TWI354101B (en) | 2008-08-19 | 2011-12-11 | Univ Nat Taipei Technology | Fluorimetric indicator for biosensing and manufact |
| DK2456864T3 (en) | 2009-05-01 | 2015-12-21 | Promega Corp | SYNTHETIC OPLOPHORUS luciferases WITH IMPROVED LIGHT MISSION |
| WO2011038219A1 (en) | 2009-09-24 | 2011-03-31 | Promega Corporation | Proteases having improved stability, solubility and activity |
| EP2569423B1 (en) | 2010-05-11 | 2015-12-02 | Promega Corporation | Mutant protease biosensors with enhanced detection characteristics |
| WO2011146390A2 (en) * | 2010-05-17 | 2011-11-24 | The Regents Of The University Of California | Compositions and methods for in vivo imaging |
| EP2611929B1 (en) | 2010-09-01 | 2016-01-13 | Promega Corporation | Oxidized glutathione assay |
| US9284188B2 (en) | 2010-09-03 | 2016-03-15 | The Regents Of The University Of California | Cytosolic delivery of materials with endosome-disrupting colloids |
| US8632992B2 (en) | 2010-09-10 | 2014-01-21 | Promega Corporation | Methods for assaying enzyme activities |
| PT2635583E (pt) | 2010-11-02 | 2015-09-11 | Promega Corp | Derivados da coelenterazina e métodos de utilização da mesma |
| US8669103B2 (en) | 2010-11-02 | 2014-03-11 | Promega Corporation | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| EP2751089B1 (en) | 2011-09-02 | 2018-11-14 | Promega Corporation | Compounds and methods for assaying redox state of metabolically active cells and methods for measuring nad(p)/nad(p)h |
| EP2900833B1 (en) * | 2012-09-26 | 2018-05-30 | Promega Corporation | Real-time monitoring |
| US9927430B2 (en) | 2014-01-29 | 2018-03-27 | Promega Corporation | Pro-substrates for live cell applications |
| WO2015116867A1 (en) | 2014-01-29 | 2015-08-06 | Promega Corporation | Quinone-masked probes as labeling reagents for cell uptake measurements |
-
2015
- 2015-01-29 US US14/608,910 patent/US9927430B2/en active Active
- 2015-01-29 EP EP15703218.6A patent/EP3099691B1/en active Active
- 2015-01-29 WO PCT/US2015/013504 patent/WO2015116806A1/en not_active Ceased
- 2015-01-29 JP JP2016549241A patent/JP6588917B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240068009A1 (en) | SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS LUCIFERASE SUBSTRATES | |
| JP6588917B2 (ja) | 生細胞への適用のためのプロ基質 | |
| US20220071995A1 (en) | Compositions and methods for cancer expressing pde3a or slfn12 | |
| EP2454261B1 (en) | Imidazo[1,2-alpha]pyrazin-3(7h)-one derivatives bearing a new electron-rich structure | |
| JP2020504754A5 (enExample) | ||
| EP1476459A4 (en) | INHIBITION OF RNA INTERFERENCE-INDUCED CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | |
| Wijkmans et al. | Inhibitors of cathepsin K: a patent review (2004–2010) | |
| Verga‐Gérard et al. | Hepatitis C virus/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF‐β signaling | |
| Liang et al. | A genetically encoded copper (I) sensor based on engineered structural distortion of EGFP | |
| US20190010157A1 (en) | Serum stable pro-coelenterazine analogues | |
| Košmrlj et al. | Diazenes as powerful and versatile tools in organic synthesis | |
| Poddutoori et al. | Discovery of MAP855, an efficacious and selective MEK1/2 inhibitor with an ATP-competitive mode of action | |
| Ahn et al. | Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X‐RNA | |
| US7718389B2 (en) | Stabilizing composition and stabilizing method of coelenterazine solution for high-throughput measurement of luciferase activity | |
| Leila et al. | Symmetric anti-HCV agents: synthesis, antiviral properties, and conformational aspects of core scaffolds | |
| Zeng et al. | Targeting oncogenic K-Ras mutants with a small-molecule degrader through Nedd4-1 | |
| Wang et al. | Current drug discovery for anti-hepatitis C virus targeting NS4B | |
| Poulsen et al. | Multiplexed screen identifies a Pseudomonas aeruginosa-specific small molecule targeting the outer membrane protein OprH and its interaction with LPS | |
| Shirley | Synthesis and Characterization of Antifungal Kinase Inhibitors and β-Lactam Antibiotics | |
| JP2008026298A (ja) | ハイスループット発光活性測定のためのセレンテラジン（ウミシイタケルシフェリン）溶液の安定化組成物および安定化法 | |
| Son et al. | Synthesis and Structure–Activity Relationship of Novel Indole Acrylamide Derivatives as HCV Replication Inhibitors | |
| WO2025151850A1 (en) | Spirocycle acrylamides that stereo- and site-selectively degrade the transcriptional and dna-damage response protein ercc3 | |
| Sneyers et al. | BAPTA, the intracellular calcium chelator: how does it kill cancer cells? | |
| EA200700206A1 (ru) | Соль щавелевой кислоты с 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-дионом, способ её получения и применение | |
| Rakic | Small molecule effects on Hepatitis C Virus. |